February 13, 2025:

A correlative study related to the Big Ten Cancer Research Consortium (Big Ten CRC) clinical trial, BTCRC-GU15-023, titled, “Phase Ib/II Study of Concurrent Durvalumab And Radiation Therapy (DUART) Followed by Adjuvant Durvalumab in Patients with Urothelial Cancer (T2-4 N0-2 M0) of the Bladder,” will be presented as a poster presentation at American Society of Clinical Oncology® (ASCO) Genitourinary Cancers Symposium 2025 by Adriana S. Ramos-Medero of Ponce Health Sciences University School of Medicine.

Read More

February 11, 2025: 

The Big Ten Cancer Research Consortium (Big Ten CRC), a collaboration of the cancer centers of Big Ten Conference universities united to transform cancer research by leveraging their scientific and clinical expertise, welcomed new member Fred Hutch Cancer Center, an independent, nonprofit organization that serves as the cancer program for UW Medicine (the University of Washington’s health system). It is the first new institution to join the consortium following the recent expansion of the Big Ten Conference.

Read More